Article
Selective inhibition of Biotin Protein Ligase from Staphylococcus aureus
23 Mar 2012
Abstract excerpt
There is a well documented need to replenish the antibiotic pipeline with new agents to combat the rise of drug resistant bacteria. One strategy to combat resistance is to discover new chemical classes immune to current resistance mechanisms that inhibit essential metabolic enzymes. Many of the obvious drug targets that have no homologous isozyme in the human host have now been investigated. Bacterial drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
